NAMS - Balance Sheet - NewAmsterdam Pharma Company N.V.

Current Liabilities	107 M
Accounts Payable	4.74 M
Short-Term Debt	246 K
Other Current Liabilities	102 M
Non-Current Liabilities	202 K
Long-Term Debt	0
Other Non-Current Liabilities	202 K

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020
ASSETS
Cash & Cash Equivalents	771.7	340.4	438.5	53.1	7.9
Short Term Investments	62.4	0	0	0	0
Receivables	0	1.9	2.1	4.9	0
Inventory	0	0	21.5 K	735	0
Other Current Assets	0	4.5	8.2	7.5	1.7
Total Current Assets	863.4	346.8	448.1	58.9	9.2
PP&E	0.7	0.1	0.1	0.2	12 K
Intangible Assets	0.5	0.2	82.9	0	0
Goodwill	0	0	0.2	0	0
Long Term Investments	0	0	0	0.7	112.8
Other Long Term Assets	0	35 K	0.1	353	(112.8)
Other Assets	0	0	0	0	0
Total Assets	864.6	347.1	531.6	59.8	9.2
LIABILITIES
Accounts Payable	4.7	16.9	11.9	7.0	0.5
Short Term Debt	0.2	60 K	66 K	60 K	11.7
Other Current Liabilities	95.9	24.0	9.7	1.3	0.7
Total Current Liabilities	106.9	49.9	35.5	9.9	12.8
Long Term Debt	0	0	60 K	0.1	0
Deferred Tax Income	0	0	0	0	0
Other Liabilities	0	7.8	6.7	14.7 K	0
Total Liabilities	107.1	58.7	47.1	10.0	12.8
EQUITY
Common Stock	13.4	10.2	599.2	83.9	2.5
Retained Earnings	0	(317.0)	(119.4)	(34.7)	(6.1)
Other Accumulative Comprehensive Income/Loss	4.5	4.4	4.7	0.6	0
Total Equity	757.5	288.4	484.5	49.8	(3.6)
Total Liabilities and Equity	864.6	347.1	531.6	59.8	9.2
SHARES OUTSTANDING
Common Shares Outstanding	94.4	82.2	19.0	17.8	17.8

Free